BGM Group Ltd BGM
Annual
Quarterly
FY2025 · ended Sep 30, 2025 · Revenue $37.92M, +51.1% YoY · Filed Jul 21, 2026
BGM Group Ltd (BGM) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Sep 30, 2025, it reported revenue of $37.9 million and a net loss of $19.9 million. Free cash flow was -$3.9 million. As of Sep 30, 2025 it held $21.3 million in cash and investments and $320,254 in total debt.
Revenue
$37.92M
+51.1% vs prior year
Net income
$-19.94M
-1282.1% vs prior year
Operating cash flow
$-2.37M
-535.9% vs prior year
Free cash flow
$-3.94M
-1395.3% vs prior year
EPS
$-0.18
+10.0% vs prior year
Dividend per share
None
Shares outstanding
200.62M
+2676.2% vs prior year
Net cash
$20.99M
FY 2025
Operating margin
-33.2%
FY 2025
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BGM (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- Cayman Islands
- Headquarters
- Chengdu
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1779578
- Former names
- Qilian International Holding Group (until Oct 22, 2024); Qilian International Holding Group Ltd (until Oct 16, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Sep 30, 2025 |
FY 2024 Sep 30, 2024 |
FY 2023 Sep 30, 2023 |
FY 2022 Sep 30, 2022 |
FY 2021 Sep 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $37.9M | $25.1M | $46.5M | $64.9M | $57.1M |
| Operating income | -$12.6M | -$563,771 | -$2.6M | $2.1M | $2.4M |
| Net income | -$19.9M | -$1.4M | -$7.8M | $1.1M | $3.2M |
| Diluted EPS | -$0.18 | -$0.20 | -$1.08 | $0.15 | $0.09 |
| Operating cash flow | -$2.4M | $544,238 | $312,209 | $12.7M | $345,034 |
| Free cash flow | -$3.9M | $304,105 | $132,450 | $10.6M | -$1.1M |
| Total assets | $433.8M | $53.0M | $51.3M | $64.5M | $75.4M |
| Total liabilities | $41.9M | $8.9M | $6.9M | $9.6M | $18.7M |
| Stockholders' equity | $390.9M | $42.7M | $42.8M | $53.1M | $54.9M |
| Cash and investments | $21.3M | $13.2M | $9.1M | $14.9M | $11.1M |
| Total debt | $320,254 | — | $98,135 | $96,396 | $162,027 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Sep 24, 2026 | Sep 24, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
| 6-K | Current report (foreign issuer) | Aug 28, 2026 | Aug 28, 2026 |
| 6-K | Current report (foreign issuer) | Aug 11, 2026 | Aug 11, 2026 |
| 6-K | Current report (foreign issuer) | Jul 30, 2026 | Jul 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 28, 2026 | Jul 28, 2026 |
All 154 BGM Group Ltd SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.